CLIA Chlamydia pneumoniae
Chemiluminescence kit for the detection of IgG, IgA or IgM antibodies to Chlamydia pneumoniae
in human serum or plasma
in human serum or plasma
Chlamydiae are gram-negative bacteria, obligate intracellular parasites. Among them, Chlamydia pneumoniae is the most widespread species in the human population and can cause respiratory tract infections, such as pneumonia. In recent years, the number of acute and chronic infections has increased. The primary infection usually occurs between 5 and 18 years of age. The typical clinical symptoms include rhinitis, sinusitis, otitis media, pharyngitis, bronchitis, atypical pneumonia with non-productive cough and indistinctive auscultatory findings. In the past 20 years, researchers have linked a wide variety of diseases to C. pneumoniae infection.
Produkte
Advantages
- Detection of IgG, IgA or IgM antibodies to Chlamydia pneumoniae
- Disease stage specification
- Intended for human serum and plasma
- The purified and inactivated antigen of C. pneumoniae used
- The kits are CE-IVD certified and intended for professional use
- For each CLIA kit a corresponding control set is available
| Assay stability | 30 days in-board-stability / in-use-stability until the expiration date at storage temperature 2-8 °C |
| Sample matrix | Serum, Plasma |
| Sample volume | 10 µL |
| Measuring range | 5 - 320 U/ml (IgG), 5-100 U/ml (IgA + IgM), |
| Assay/kit content | Reagent Cartridge with specific reagents for the assay, magnetic particles, calibrators |